Artigo de periodico

Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting (2019)

• Authors:
  • Dartora, Vanessa Franco Carvalho
  • Salata, Giovanna Cassone
  • Matos, Jenyffer Kelly Rocha de
  • Fernandez, Sandra Costa
  • Chorilli, Marlus
  • Steiner, Alexandre Alarcon
  • Araujo, Gabriel Lima Barros de
  • Silveira, Edilberto Rocha
  • Lotufo, Leticia Veras Costa
  • Lopes, Luciana Biagini
• USP affiliated authors: STEINER, ALEXANDRE ALARCON - ICB ; ARAUJO, GABRIEL LIMA BARROS DE - FCF ; LOTUFO, LETICIA VERAS COSTA - ICB ; LOPES, LUCIANA BIAGINI - ICB ; MATOS, JENYFFER KELLY ROCHA DE - ICB ; DARTORA, VANESSA FRANCO CARVALHO - ICB ; SALATA, GIOVANNA CASSONE - ICB ; FERNANDEZ, SANDRA COSTA - ICB
• Unidades: ICB; FCF
• DOI: 10.1016/j.ijpharm.2019.118460
• Subjects: FARMACOLOGIA; IMUNOLOGIA; NEOPLASIAS MAMÁRIAS; CITOTOXICIDADE IMUNOLÓGICA; QUITOSANA
• Agências de fomento:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
    Processo FAPESP: 2013/16617-7
• Language: Inglês
• Imprenta:
  • Publisher place: Amsterdam
  • Date published: 2019
• Source:
  • Título do periódico: International Journal of Pharmaceutics
  • ISSN: 1873-3476
  • Volume/Número/Paginação/Ano: v. 567, art. 118460, 13 p., 2019

Informações sobre o DOI: 10.1016/j.ijpharm.2019.118460 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: publisher-specific-oa

---

Download do texto completo

Tipo	Nome	Link
	2960731_Postprint.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  DARTORA, Vanessa Franco Carvalho et al. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, v. 567, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2019.118460. Acesso em: 16 abr. 2024.

• APA

  Dartora, V. F. C., Salata, G. C., Matos, J. K. R. de, Fernandez, S. C., Chorilli, M., Steiner, A. A., et al. (2019). Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, 567, 13 . doi:10.1016/j.ijpharm.2019.118460

• NLM

  Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Lotufo LVC, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460

• Vancouver

  Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Lotufo LVC, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
• Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration
• Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation
• Improvement of cutaneous delivery of methylene blue by liquid crystals
• Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
• Development of a method for quantitative determination of the cytotoxic agent piplartine (piperlongumine) in multiple skin layers
• Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
• Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models
• A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
• Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide